Haoxi Health Technology Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing, dated December 19, 2024, is a report of other events for Haoxi Health Technology Limited, a foreign private issuer headquartered in Beijing, China. The filing serves to notify shareholders of the upcoming Annual General Meeting (AGM) and includes the Notice of the meeting and a Proxy Card as exhibits.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding corporate governance and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The primary event is the scheduling of the Annual General Meeting of Shareholders.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or specific risk factors. It notes that the Notice of the AGM is not subject to SEC review and urges shareholders to read the attached documents for important information regarding the meeting and proxy solicitation.
Key Facts for Investors
- The company is holding an Annual General Meeting of Shareholders.
- Exhibit 99.1 contains the Notice of the meeting and Proxy Statement.
- Exhibit 99.2 contains the Proxy Card.
- Shareholders may obtain copies of these documents from the SEC website or the company's website at http://www.haoximedia.com/.
- The filing was signed by Zhen Fan, Chief Executive Officer, on December 19, 2024.